HomeCompareKWIPF vs MRK

KWIPF vs MRK: Dividend Comparison 2026

KWIPF yields 3.58% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.1K in total portfolio value
10 years
KWIPF
KWIPF
● Live price
3.58%
Share price
$0.51
Annual div
$0.02
5Y div CAGR
-37%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.7K
Annual income
$3.71
Full KWIPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KWIPF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKWIPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KWIPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KWIPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KWIPF
Annual income on $10K today (after 15% tax)
$304.56/yr
After 10yr DRIP, annual income (after tax)
$3.15/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,325.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KWIPF + MRK for your $10,000?

KWIPF: 50%MRK: 50%
100% MRK50/50100% KWIPF
Portfolio after 10yr
$38.7K
Annual income
$4,900.93/yr
Blended yield
12.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KWIPF
No analyst data
Altman Z
1.1
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KWIPF buys
0
MRK buys
0
No recent congressional trades found for KWIPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKWIPFMRK
Forward yield3.58%2.76%
Annual dividend / share$0.02$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-37%32.7%
Portfolio after 10y$20.7K$56.8K
Annual income after 10y$3.71$9,798.13
Total dividends collected$617.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KWIPF vs MRK ($10,000, DRIP)

YearKWIPF PortfolioKWIPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,926$225.73$11,206$366.19$280.00MRK
2$11,836$145.21$12,650$502.35$814.00MRK
3$12,757$92.62$14,407$694.19$1.6KMRK
4$13,709$58.78$16,585$967.82$2.9KMRK
5$14,705$37.19$19,342$1,363.89$4.6KMRK
6$15,758$23.49$22,913$1,947.19$7.2KMRK
7$16,876$14.82$27,662$2,823.89$10.8KMRK
8$18,067$9.34$34,159$4,173.35$16.1KMRK
9$19,337$5.89$43,337$6,308.80$24.0KMRK
10$20,695$3.71$56,776$9,798.13$36.1KMRK

KWIPF vs MRK: Complete Analysis 2026

KWIPFStock

Kiwi Property (NZX: KPG) is one of the largest listed property companies on the New Zealand Stock Exchange and is a member of the S&P/NZX 20 Index. We've been around for over 25 years and proudly own, and manage a significant real estate portfolio, comprising some of New Zealand's best mixed-use, retail and office buildings. Our objective is to provide investors with a reliable investment in New Zealand property through the ownership and active management of a diversified, high-quality portfolio. S&P Global Ratings has assigned Kiwi Property an issuer credit rating of BBB (stable) and an issue credit rating of BBB+ for each of its fixed rate senior secured bonds. Kiwi Property is the highest rated New Zealand company within CDP (Carbon Disclosure Project) and is a member of FTSE4 Good, a series of benchmark and tradable indices for ESG (Environmental, Social and Governance) investors. Kiwi Property is licensed under the Real Estate Agents Act 2008.

Full KWIPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KWIPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KWIPF vs SCHDKWIPF vs JEPIKWIPF vs OKWIPF vs KOKWIPF vs MAINKWIPF vs JNJKWIPF vs ABBVKWIPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.